TEVA 8-K: Executive departure
Filed with the SEC on · accession 0001193125-26-467276
TEVA filed a 8-K (current report) with the SEC on Nov 18, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Summary of the filing
Dr. Eric Hughes, Executive Vice President, Global R&D and Chief Medical Officer of Teva Pharmaceutical Industries, notified the company on November 17, 2026 of his intention to resign, stepping down immediately from his role while assisting with a transition over the next few months.
Key details
✦ Ask GOAX AI about this filing — what it means for TEVA, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for TEVA?
Click hereFrequently asked questions
What did TEVA file with the SEC on Nov 18, 2026?
TEVA filed a 8-K (Executive departure). Dr. Eric Hughes, Executive Vice President, Global R&D and Chief Medical Officer of Teva Pharmaceutical Industries, notified the company on November 17, 2026 of his intention to resign, stepping down immediately from his role while assisting with a transition over the next few months.
What does a executive departure mean for TEVA stock?
Not always. A planned retirement with a successor is usually calm; a sudden departure “effective immediately”, especially of a CFO or near results, often worries investors.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other TEVA SEC filings
- SCHEDULE 13G/A · SEC filingNov 16, 2026
- SCHEDULE 13G/A · SEC filingNov 10, 2026
- 8-K · Guidance raiseNov 3, 2026
- 10-Q · SEC filingNov 3, 2026
- SCHEDULE 13G/A · SEC filingNov 2, 2026
- 8-K · SEC filingOct 29, 2026
- 8-K · Material agreementSep 16, 2026
- 8-K · SEC filingSep 14, 2026
- 8-K · SEC filingSep 11, 2026
- 424B5 · Secondary offeringSep 11, 2026
Get alerts when TEVA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days